ARCEDI is a Danish biotechnology company that develops non-invasive prenatal diagnosis (NIPD) products. The company specializes in developing safe and reliable diagnostic tests for fetal chromosomal abnormalities, such as Down syndrome, without the need for invasive procedures. ARCEDI uses a unique approach to NIPD, which involves analyzing cell-free fetal DNA in maternal blood.

Since the outbreak of COVID-19, governments worldwide have invested enormous resources in scaling up their testing capacity. PCR testing is the most reliable test method, but it can take several hours to a few days to deliver test results, leaving a window in which infection may spread. Olfert Landt, CEO of TIB Molbiol, identified the need for a shorter lead time and came up with the idea to develop a continuous PCR test machine. Samples are not moved through the testing process in batches as is normally done, but one by one, reducing the total testing time significantly.

Grouleff DK specializes in developing and producing medical equipment and was tasked with delivering a specially designed chair and bed for a MEG (magnetoencephalography) scanner. A MEG scanner maps the magnetic signals of a brain and requires a stable and uninterrupted scan to produce accurate images. Grouleff DK was approached by an English customer to create a chair and a bed in anti-magnetic materials with fine-mechanical solutions to fit their customer’s MEG scanner precisely. As this was the first time Grouleff DK had created a chair and a bed for a MEG scanner, they required external resources to complete the task and turned to DIS/CREADIS for assistance.